Sun Pharma eyes $12B Organon acquisition with financing plans

Sun Pharma eyes $12B Organon acquisition with financing plans — Sun Pharma is actively evaluating financing options for its proposed $12 billion acquisition of US-based Organon, marking a major strategic expansion. The deal, if completed, would be one of the largest in Indian pharma history. $12 billion underscores the scale and global ambition.

📊 STOCKS: SUNPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition